Bayer AG NA (BAYN) - Stock Price & Dividends

Exchange: XETRA Stock Exchange • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000BAY0017

Pharmaceuticals, Crop Science, Consumer Health

Bayer AG, a leading life science company, operates globally through three main segments: Pharmaceuticals, Consumer Health, and Crop Science.

The Pharmaceuticals segment is a significant player in the healthcare industry, offering a range of prescription products focused on cardiology and women's health care. Additionally, it provides specialty therapeutics in areas such as oncology, hematology, and ophthalmology. The segment also offers diagnostic imaging equipment, digital solutions, and contrast agents, as well as cell and gene therapy solutions.

The Consumer Health segment is a prominent player in the self-care market, offering a wide range of non-prescription, over-the-counter medicines for self-medication and self-care. Its product portfolio includes nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health solutions.

The Crop Science segment is a major player in the agricultural industry, providing innovative solutions for farmers worldwide. It offers high-quality seeds, improved plant traits, and a range of chemical and biological crop protection products. The segment also provides digital solutions, customer service, and breeding, propagation, and production/processing of seeds, including seed dressing.

Bayer AG has established several strategic collaborations with leading companies and institutions, including Acuitas Therapeutics, Peking University, the Swiss Tropical and Public Health Institute, bit.bio Ltd., Hologic, Inc., Twist Bioscience Corporation, CrossBay Medical Inc., and Thermo Fisher Scientific. These collaborations focus on gene editing, pharmaceutical research, and the development of innovative therapeutics and diagnostic solutions.

The company distributes its products through a wide range of channels, including wholesalers, pharmacies, supermarkets, online retailers, and hospitals, as well as directly to farmers. With a rich history dating back to 1863, Bayer AG is headquartered in Leverkusen, Germany, and is committed to improving lives through its innovative life science solutions.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Bayer AG NA (BAYN) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Bayer AG NA (BAYN) - Stock Price & Dividends

BAYN Stock Overview

Market Cap in USD 30,616m
Sector Healthcare
Industry Drug Manufacturers - General
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception

BAYN Stock Ratings

Growth 5y -3.52
Fundamental -9.37
Dividend 4.81
Rel. Performance vs Sector -7.42
Analysts -
Fair Price Momentum 24.14 EUR
Fair Price DCF 56.24 EUR

BAYN Dividends

Yield 12m 0.38%
Yield on Cost 5y 0.24%
Dividends CAGR 5y -3.04%
Payout Consistency 92.8%

BAYN Growth Ratios

Growth 12m -47.09%
Growth Correlation 12m -78%
Growth Correlation 3m 16%
CAGR 5y -8.95%
CAGR/Mean DD 5y -0.36
Sharpe Ratio 12m -1.75
Alpha vs SP500 12m -69.36
Beta vs SP500 5y weekly 0.74
ValueRay RSI 81.65
Volatility GJR Garch 1y 25.01%
Price / SMA 50 4.83%
Price / SMA 200 -19.83%
Current Volume 1420.2k
Average Volume 20d 3460.3k

External Links for BAYN Stock

Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of BAYN stocks?
As of May 21, 2024, the stock is trading at EUR 28.67 with a total of 1,420,239 shares traded.
Over the past week, the price has changed by -2.43%, over one month by +9.33%, over three months by +0.05% and over the past year by -47.28%.
What are the forecast for BAYN stock price target?
According to ValueRays Forecast Model, BAYN Bayer AG NA will be worth about 26.1 in May 2025. The stock is currently trading at 28.67. This means that the stock has a potential downside of -9.07%.
Issuer Forecast Upside
Wallstreet Target Price 34.8 21.4
Analysts Target Price - -
ValueRay Target Price 26.1 -9.07